Reid Hayward Eggleston, MD

NPI 1164041356ActiveIndividual· Internal Medicine, Pulmonary Disease· Rochester, MN

Internal Medicine, Pulmonary Disease (MD) in Rochester, Minnesota, trained at University of Kansas School of Med (Kc/Wich/Sal) (class of 2020). Their prescriptions cost Medicare Part D more than their services did: $62,543 for 113 claims, against $3,971 paid for services in 2024. Astrazeneca Pharmaceuticals LP reported $26.25 in payments in 2025, mostly food and beverage.

Overview

NPI	1164041356
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Apr 8, 2020
Last updated in NPPES	Jun 30, 2023
Certified by provider	Jun 30, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	69567	MN
Internal Medicine	207R00000X	69567	MN
Internal Medicine	207R00000X	30884	MN

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (MN); Practitioner - Pulmonary Disease (MO)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	28
Services billed	36 across 6 procedure codes
Paid by Medicare	$3,971

Part D prescriptions in 2024

Prescriptions (claims)	113 · 175 30-day fills
Patients	27
Total drug cost	$62,543
Generic share	57% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Kansas School of Med (Kc/Wich/Sal)
Graduation year	2020
Medicare specialty	Pulmonary Disease
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth